MBA Candidate at University of York (2026-03 – Present)
After thirteen years working across institutional financial services — and following the loss of my mother to cancer in 2010 and my father to dementia in 2021 — I made a deliberate decision to deepen my expertise in healthcare management and formalise the strategic and commercial knowledge I have been applying in practice since 2009 as a founding equity partner of Mobile Health Group New Zealand. Both losses profoundly shaped my conviction that access to better-designed, better-funded and better-delivered healthcare systems saves lives. That conviction has sat alongside my financial services career for over a decade, expressed through our family's founding involvement in Mobile Health Group NZ, where we have backed and scaled a portfolio of mobile medical and surgical technology businesses across New Zealand with the explicit goal of expanding access to care in underserved communities.
Enrolling in the University of York's MBA in Healthcare Management is the natural next step — giving rigorous academic grounding to what has been a deeply personal and commercially active parallel commitment. The programme, undertaken on a part-time basis over two years, covers healthcare strategy, systems leadership, service design and policy — directly equipping me to operate at the intersection of institutional capital, technology and healthcare delivery that defines the most impactful organisations in this space today.
Associate Commercial Director at Ocorian (2025-02-03 – 2026-02-18)
- Led global business development strategy across ANZ and EMEA, with a focus on cross-selling capital markets, fund, and treasury solutions to asset managers, wealth managers, hedge funds and VCs
- Delivered treasury-adjacent solutions including cash management, FX hedging and international payments through partnerships with FX/IR sales traders, directly supporting the treasury growth strategy
- Originated and closed new business across AIFM, depositary, fund administration, SPV, and SaaS asset management platforms (eFront, BlackRock Aladdin)
- Built and scaled intermediary networks spanning lawyers, consultants, bankers and prime brokers across multiple jurisdictions, contributing to 30% YoY wallet share growth
- Ensured proposals met regulatory requirements through close collaboration with legal, compliance, risk and operations teams
- Maintained Salesforce pipeline hygiene across opportunity lifecycle — from initial engagement through to won-live — supporting accurate revenue capture and forecasting
Institutional Sales & Relationship Manager at EMFI Group (2022-01-17 – 2025-01-31)
- Drove electronic fixed income flow business by marketing and distributing Trumid's e-Fixed Income trading platform to banks, asset managers, hedge funds and broker-dealers, directly growing electronic market share across institutional client segments
- Managed venue relationships with Trumid, monitoring electronic trading performance, client activity and wallet share, and conducting regular positioning reviews to optimise platform engagement and revenue capture
- Covered CEEMEA and LATAM-facing institutional clients including NBFIs, asset managers and portfolio managers, executing cross-asset fixed income sales across EM bonds, rates and cash equities with a focus on electronic and hybrid execution channels
- Built and maintained senior relationships with portfolio managers and C-suite decision-makers at non-banking financial institutions, identifying new electronic trading opportunities and driving client onboarding and enablement across e-trading workflows
- Delivered macro research sales and distribution to EM-focused portfolio managers, translating macroeconomic developments across CEEMEA and LATAM into actionable, revenue-generating client engagement
- Partnered with voice trading teams to maximise total franchise volumes across electronic and hybrid channels
Full Time Carer (2019-08-23 – 2021-08-06)
On the 30th of November 2019 I resigned from Valbury Capital to look after my father who was diagnosed with Dementia up until he passed away in August 2021.
Institutional Sales & Relationship Manager at Valbury Capital (2016-07-05 – 2019-11-29)
- Drove electronic and voice fixed income flow business across EM-focused institutional clients, distributing multi-asset execution services spanning fixed income, FX and cash equities to banks and NBFIs across CEEMEA and LATAM regions
- Proactively identified and converted new electronic trading opportunities across prime services, multi-asset liquidity and derivatives solutions, growing wallet share with sophisticated institutional investors through disciplined, data-driven client engagement
- Monitored client trading activity, venue performance and electronic execution trends, developing strategies to increase electronic market share and deepen client penetration across hybrid and fully electronic channels
- Acted as primary point of contact for key institutional accounts, representing the firm at client roadshows and corporate access events and maintaining trusted C-level relationships across banking and NBFI client segments
- Partnered with senior sales traders to deliver primary coverage to institutional clients, supporting enablement across electronic trading products and resolving execution and workflow issues in collaboration with middle office and technology teams
- Ensured seamless client onboarding, trade lifecycle management and regulatory alignment across a dynamic, fast-paced multi-asset environment
Head of Business Development & Private Equity Partner at Urology Group - New Zealand (2009-06-30 – 2016-05-27)
- Developed and executed a comprehensive business development strategy across primary surgical services, clinical care and digital healthcare delivery, driving geographic expansion into underserved rural markets across New Zealand — directly analogous to Meena Health's multi-service-line growth mandate across the Kingdom
- Built and managed strategic partnerships with government entities, corporate and institutional investors including the Ministry of Health, Westpac Group, Deloitte and PwC, leading negotiations, contracting and long-term partnership agreements across public and private sectors
- Secured public and institutional funding to scale surgical capacity, owning the full deal lifecycle from opportunity identification and business case development through to close and deployment — consistently delivering against large-scale revenue and growth targets
- Led GTM strategy for surgical services across primary and specialist care settings, expanding B2B channels through employer health programmes, institutional contracts and provider adoption initiatives
- Executed private equity-led investments into a portfolio of mobile medical and surgical technology businesses across New Zealand as Equity Partner of Mobile Health Group NZ, conducting market analysis, competitor benchmarking and opportunity assessment to identify and convert high-value healthcare investment targets
- Partnered with Westpac, Deloitte and PwC to structure and execute PE investment transactions, managing deal governance, financial modelling and commercial performance tracking across the portfolio
- Established KPIs, reporting frameworks and performance tracking mechanisms across commercial and clinical service lines, collaborating closely with operations, finance and medical leadership teams to ensure strategic alignment and delivery
